EUCOPE News by Tag — HTA

Filtered by Tag: HTA

EUCOPE Resources / News - September 19, 2023

EVENT RECAP – Life Science Lectures: Episode Three “‘’EU HTA: How will the revised Pharma Package impact the value assessment of therapies?’’

On 7 September, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, hosted the third episode of its #LifeScienceLectures webinar series.  The focus of the webinar, titled ‘’EU HTA: How will the revised Pharma Package impact the value assessment of therapies?’’ was to shed light on the… read more

EUCOPE Resources / News / Press Releases - October 26, 2022

EUCOPE/EFPIA Joint Statement: Concerns over the implementation of the EU HTA Regulation

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have concerns on the current direction of the implementation of the EU HTA Regulation. We are firmly convinced that the input from patient organizations, healthcare professionals, industry and HTA experts and… read more

News - April 6, 2022

The Implications Of The New EU HTA Regulation For Companies

Joint Clinical Assessments Will Become A Key Part Of The New Environment Regulation (EU) 2021/2282 on health technology assessment (HTA) is now in force and will bring important and wide-reaching changes that pharmaceutical companies need to understand. Arguably the most important implication of the regulation… read more